 |
|
|
|
|
|
 |
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
| . |
Filtration efficiency
is the measurement of a filter’s capacity to effectively
remove particulates, such as virus and bacterium, from moisture or air
over
a specified period of time. It should be noted that the number of
digits after
the decimal point (i.e. .99 vs. .999) is a function of the test and not
necessarily
a reflection of filter performance. It should also be noted that
it is common to
challenge air filters at 0.3 microns during filtration efficiency testing
on the
premise that if water droplets, or other large particles, are removed
from an
air stream all pathogens are removed as well.
While it is obviously much easier to achieve a favorable result at 0.3
microns;
it has been proven that relative efficiencies will diminish as the contaminates
decrease in size (virus are much smaller than bacterium), when filters
are
subjected to higher volumes of airflow or higher quantities of particulate,
and when filters are in use over a prolonged period of time. Efficiency
is
more meaningful then when stated in terms of percentage of efficiency
and
particulate size. To put this into perspective, the image to the
left shows the
relative differential between 0.3 microns and 0.027 microns (the challenge
particulates size for 2H Technology testing) and the following chart demonstrates
why testing below
0.3 microns in size is relevant. |
 |
|
|
|
|
|
| Species |
| Bacteriophage
ØX174 |
| Hepatitis Virus (HBV) |
| Adenovirus |
| HIV |
| Filoviruses |
| Bunyaviridae |
| Orthomyxoviridae |
| Coronaviridae (SARS-CoV) |
| Varicella-Zoster Virus |
| Cytomegalovirus |
| Variola Virus |
|
| Size in
Microns |
| 0.025
to 0.027 diameter |
| 0.042 to 0.047 diameter |
| 0.07 to 0.09 diameter |
| 0.08 to 0.11 diameter |
0.08 diameter
0.79 to 0.97 length |
| 0.08 to 0.12 diameter |
| 0.08 to 0.12 diameter |
| 0.10 to 0.12 diameter |
| 0.11 to 0.12 diameter |
| 0.12 to 0.20 diameter |
0.14 to 0.26 diameter
0.22 to 0.45 length |
|
| Associated Diseases |
Test
virus used by Nelson Laboratories to test
2H Technology filtration efficiencies |
| Hepatitis B |
| Respiratory Infections |
| Acquired Immunodeficiency
Syndrome |
| Ebola Virus |
| Hanta Virus |
| Influenza A, B, and
C |
| SARS |
| Herpes |
| Pneumonia, Hepatitis,
Retinitis, Encephalitis |
| Small Pox |
|
| Serratia
Marcescens |
| Pseudomonas Aeruginosa |
| Staphylococcus Aureus |
| Mycobacteriumtuberculosis |
| Bacillus Anthracis |
|
| 0.45 diameter |
0.50 to 1.0 diameter
1.5 to 4.0 length |
| 1.0 diameter |
| 1.0 to 5.0 diameter |
1.0 to 1.5 diameter
3.0 to 5.0 length |
|
Extraintestinal
Infections, Nosocomial
Infections |
Endocarditis, Pneumonia,
Osteomyelitis,
Nosocomial Infections, Meningitis, Septicemia |
Pneumonia, Osteomyelitis,
Acute Endocartis
Meningitis, Toxic Shock Syndrome, Myocarditis |
| Tuberculosis |
| Anthrax Infection |
|
| |
|
|
|
|
|
|